| AA | adenine-adenine |
| ADAMTS9 | a disintegrin and metalloproteinase with thrombospondin motifs 9 |
| AFP | alpha-fetoprotein |
| Akt (AKT) (protein kinase B) | serine/threonine protein kinase |
| ALD | alcoholic liver disease |
| ALS | acid-labile protein subunit |
| aPTT | Activated Partial Thromboplastin Time |
| BMI | body mass index |
| CLD | chronic liver diseases |
| CT | cytosine-thymine |
| ECM | extracellular matrix |
| EGF/R | epidermal growth factor/receptor |
| ERK | extracellular signal-regulated kinase |
| GG | guanine-guanine |
| GH | growth hormone |
| HBV/HCV | hepatitis B/C virus |
| HCC | hepatocellular carcinoma |
| HGF | hepatocyte growth factor |
| HIV | human immunodeficiency virus |
| HSCs | human stellate cells |
| IGF | insulin-like growth factor |
| IGFR | IGF receptor |
| IGFBPs | IGF binding proteins |
| IGFBPrP1-10 | IGF IGFBP-related proteins 1-10 |
| IL | interleukin |
| INR | International Normalized Ratio of prothrombin time of blood coagulation |
| IR | insulin receptor |
| IRS-1/2 | insulin receptor substrate 1/2 |
| kDa | kilodalton |
| LH | luteinizing hormone |
| MAPK | mitogen-activated protein kinase (originally called ERK) |
| MELD | Model of End-Stage Liver Disease |
| NAFLD | nonalcoholic fatty liver disease |
| NASH | nonalcoholic steatohepatitis |
| PI3K | phosphatidylinositol 3-kinase |
| STAT | signal transducer and activator of transcription |
| TGF-α, -β | transforming growth factor α, -β |
| TNF-α | tumor necrosis factor α |
| TNM | classification of Malignant Tumors (T—tumor; N—lymph nodes; M—metastasis) |
| TT | thymine-thymine |